Biogen's most recent MS drug approval is largely about extending patent protection
August 18, 2014 at 14:15 PM EDT
With the approval of its fifth drug to treat multiple sclerosis, Biogen Idec is offering patients the chance for twice-a-month injections rather than weekly injections...
